Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-SARS-CoV-2 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04325633
What this trial is testing

Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Ended earlyNCT04409873
What this trial is testing

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)

Who this might be right for
COVID-19SARS-CoV 2Severe Acute Respiratory Syndrome Coronavirus 2+3 more
University of California, San Francisco 54
Large-scale testing (Phase 3)Study completedNCT04324463
What this trial is testing

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Who this might be right for
CoronavirusSevere Acute Respiratory Syndrome
Population Health Research Institute 6,667
Testing effectiveness (Phase 2)UnknownNCT04834089
What this trial is testing

Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases

Who this might be right for
ImmunosuppressionCancerCOVID-19+6 more
Butantan Institute 618
Not applicableUnknownNCT04356417
What this trial is testing

Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse

Who this might be right for
AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
Assistance Publique - Hôpitaux de Paris 6,000,000
Testing effectiveness (Phase 2)UnknownNCT04404218
What this trial is testing

The Açaí Berry COVID-19 Anti-Inflammation Trial

Who this might be right for
COVID
University Health Network, Toronto 480
Testing effectiveness (Phase 2)Study completedNCT04681092
What this trial is testing

Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study

Who this might be right for
Covid19
University Medical Center Groningen 112
Large-scale testing (Phase 3)UnknownNCT04891172
What this trial is testing

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Who this might be right for
Covid19
Dow University of Health Sciences 310
Not applicableStudy completedNCT05057936
What this trial is testing

Antibody After COVID-19 Vaccination

Who this might be right for
Covid19Breakthrough InfectionCKD+2 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 140
Testing effectiveness (Phase 2)Ended earlyNCT04339426
What this trial is testing

Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection

Who this might be right for
Covid19
HonorHealth Research Institute 3
Large-scale testing (Phase 3)Study completedNCT04578158
What this trial is testing

Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19

Who this might be right for
COVID-19
Liaquat University of Medical & Health Sciences 152
Early research (Phase 1)Study completedNCT04690387
What this trial is testing

Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

Who this might be right for
COVID-19
Aivita Biomedical, Inc. 27
Large-scale testing (Phase 3)Ended earlyNCT05220397
What this trial is testing

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipient
Mark Stegall 468
Large-scale testing (Phase 3)Study completedNCT04334148
What this trial is testing

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

Who this might be right for
COVID-19
Adrian Hernandez 1,360
Not applicableNo Longer AvailableNCT04360486
What this trial is testing

Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
U.S. Army Medical Research and Development Command
Large-scale testing (Phase 3)UnknownNCT05182515
What this trial is testing

Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies

Who this might be right for
COVID-19
Centre Hospitalier St Anne 50
Not applicableStudy completedNCT04397523
What this trial is testing

Efficacy and Safety of COVID-19 Convalescent Plasma

Who this might be right for
Convalescent PlasmaCOVID-19SARS-CoV 2
Institute for Transfusion Medicine of RNM 200
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Large-scale testing (Phase 3)Ended earlyNCT04498273
What this trial is testing

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Who this might be right for
COVID-19
Frank C Sciurba 657
Early research (Phase 1)Study completedNCT04661839
What this trial is testing

A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults

Who this might be right for
COVID-19
Emergent BioSolutions 28
Next Page